|
| 37850576 | Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix. | J Pathol | 2024 |
| 38085951 | PRAME Immunohistochemistry for Distinguishing Vulvar and Vaginal Melanoma From Benign Melanocytic Nevi. | Int J Gynecol Pathol | 2024 |
| 36368129 | Profiling the immune landscape in mucinous ovarian carcinoma. | Gynecol Oncol | 2023 |
| 37580913 | Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype. | Histopathology | 2023 |
| 37935523 | FIGO 2023 endometrial cancer staging: too much, too soon? | Int J Gynecol Cancer | 2023 |
| 37773079 | Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas. | Clin Cancer Res | 2023 |
| 37494476 | Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer. | Cancer Res | 2023 |
| 37191121 | Commentary: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas by Mirkovic et al. (2023). | Histopathology | 2023 |
| 37423805 | To the editor. | Gynecol Oncol | 2023 |
| 37321155 | Harmonized molecular classification; assessment of a single-test ProMisE NGS tool. | Gynecol Oncol | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37182372 | Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085]. | Mod Pathol | 2023 |
| 37229628 | <i>QPOLE</i>: A Quick, Simple, and Cheap Alternative for <i>POLE</i> Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction. | JCO Glob Oncol | 2023 |
| 36966138 | Genomic characterization of DICER1-associated neoplasms uncovers molecular classes. | Nat Commun | 2023 |
| 36753816 | Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer. | Gynecol Oncol | 2023 |
| 36788084 | Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death. | Mod Pathol | 2023 |
| 36853794 | Reply to Comment on HPV-independent, p53-Wild-type Vulvar Intraepithelial Neoplasia: A Review of Nomenclature and the Journey to Characterize Acanthotic Precursor Lesions of the Vulva. | Mod Pathol | 2023 |
| 36853783 | p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk. | Mod Pathol | 2023 |
| 36583307 | Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs. | Am J Surg Pathol | 2023 |
| 36739268 | The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype. | Gynecol Oncol | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36828360 | Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach. | Mod Pathol | 2023 |
| 36731023 | Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol. | Int J Gynecol Pathol | 2023 |
| 33935157 | Survey on Reporting of Endometrial Biopsies From Women on Progestogen Therapy for Endometrial Atypical Hyperplasia/Endometrioid Carcinoma. | Int J Gynecol Pathol | 2022 |
| 37850594 | Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes" [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36-45]. | Gynecol Oncol | 2022 |
| 35768582 | Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression. | NPJ Precis Oncol | 2022 |
| 35703457 | Data Set for the Reporting of Carcinomas of the Vagina: Recommendations From the International Collaboration on Cancer Reporting (ICCR). | Int J Gynecol Pathol | 2022 |
| 35504673 | Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases. | Gynecol Oncol | 2022 |
| 35437330 | HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva. | Mod Pathol | 2022 |
| 35764349 | Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique. | Int J Gynecol Cancer | 2022 |
| 36100281 | Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma. | Int J Gynecol Cancer | 2022 |
| 36305537 | Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR). | Int J Gynecol Pathol | 2022 |
| 36305532 | Data Set for the Reporting of Carcinomas of the Vulva: Recommendations From the International Collaboration on Cancer Reporting (ICCR). | Int J Gynecol Pathol | 2022 |
| 36065012 | Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images. | Mod Pathol | 2022 |
| 36222710 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 |
| 33720084 | Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies. | Int J Gynecol Pathol | 2022 |
| 35257510 | The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignancies. | J Pathol Clin Res | 2022 |
| 35246332 | Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification. | Gynecol Oncol | 2022 |
| 34907997 | A Multiplex SNaPshot Assay is a Rapid and Cost-Effective Method for Detecting POLE Exonuclease Domain Mutations in Endometrial Carcinoma. | Int J Gynecol Pathol | 2022 |
| 34996131 | Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). | Histopathology | 2022 |
| 35173148 | Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes. | Nat Commun | 2022 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 34380971 | An Unusual Enteric Yolk Sac Tumor: First Report of an Ovarian Germ Cell Tumor Associated With a Germline Pathogenic Variant in DICER1. | Int J Gynecol Pathol | 2022 |
| 34543435 | The utility of color normalization for AI-based diagnosis of hematoxylin and eosin-stained pathology images. | J Pathol | 2022 |
| 32980858 | Interpretation of mismatch repair protein expression using obsolete criteria results in discrepancies with microsatellite instability and mutational testing results. Comment on Hechtman et al. Mod Pathol 2020; 33:871-879. | Mod Pathol | 2021 |
| 33720083 | SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study. | Int J Gynecol Pathol | 2021 |
| 33793971 | Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis. | Cancer | 2021 |
| 33570866 | Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists. | Int J Gynecol Pathol | 2021 |
| 33570861 | Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant Performance. | Int J Gynecol Pathol | 2021 |
| 33589443 | p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification. | Int J Gynecol Cancer | 2021 |